Related Experiment Video
Updated: May 30, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Central arterial stiffness in young adults with perinatal HIV exposure and infection
Elaine M Urbina1, Wendy Yu2, Paige L Williams2,3
1Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio.
Insights
Arterial stiffness, measured by pulse wave velocity (PWV), did not significantly differ between young adults with perinatally acquired HIV (YAPHIV) and those exposed but uninfected (YAPHEU). Cardiovascular risk reduction is recommended for all young adults.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Young adults with perinatally acquired HIV (YAPHIV) may face unique health challenges.
- Assessing cardiovascular health in this population is crucial for long-term outcomes.
Purpose of the Study:
- To compare arterial stiffness, a key cardiovascular risk indicator, between YAPHIV and young adults perinatally HIV-exposed but uninfected (YAPHEU).
Main Methods:
- Cross-sectional analysis of pulse wave velocity (PWV) and echocardiography in 150 participants (95 YAPHIV, 55 YAPHEU).
- Comparison of PWV between the two groups.
- Linear regression models assessed HIV disease severity and antiretroviral treatment (ART) associations with PWV in YAPHIV.
Main Results:
- Mean PWV was similar between YAPHIV (5.63 m/s) and YAPHEU (5.39 m/s).
- Most YAPHIV had well-controlled HIV (82% viral load <400 copies/ml) and used combination ART (91%).
- Weak correlations were found between PWV and echocardiographic measures; HIV severity and ART type showed no significant association with PWV.
Conclusions:
- No significant difference in arterial stiffness (PWV) was observed between YAPHIV and YAPHEU.
- Current HIV management appears to maintain normal arterial stiffness in YAPHIV.
- Adherence to cardiovascular risk reduction guidelines is essential for all young adults to prevent cardiovascular disease.
Objective:
The aim of this study was to compare arterial stiffness between young adults with perinatally acquired HIV (YAPHIV) and young adults' perinatally HIV exposed but uninfected (YAPHEU).
Design:
A cross-sectional analysis of pulse wave velocity (PWV) measures among participants with echocardiography in the PHACS Cardiac Toxicity Substudy.
Methods:
A total of 150 participants (95 YAPHIV, 55 YAPHEU, mean 23.4 years, 60% female, 72% Black, 24% Hispanic) had echocardiography and PWV measured. We compared PWV between groups. Among YAPHIV, we fit linear regression models to evaluate the association of measures of HIV disease severity and antiretroviral treatment (ART) with PWV. We computed correlations between PWV and measures of left ventricular structure and function.
Results:
Mean PWV did not differ by group (YAPHIV 5.63 vs. YAPHEU 5.39 m/s; P = 0.50). HIV control was good (82% with viral load <400 copies/ml); 91% used combination ART. Mean PWV was normal, but three of 95 YAPHIV (3%) had values above 11.8 m/s (level associated with cardiovascular events in adults). Weak correlations (<0.20) were observed between PWV and echocardiographic measures. Among YAPHIV, current and historical HIV severity measures were not associated with PWV. YAPHIV on protease inhibitor based ART had higher mean PWV than those on integrase strand inhibitors (1.68 m/s higher, 95% confidence interval -0.36, 3.72) or nonnucleoside transcriptase inhibitors (1.58 m/s higher, 95% confidence interval -0.94, 4.11).
Conclusion:
Our data show no difference in PWV between those perinatally exposed to and perinatally infected with HIV. Therefore, cardiovascular risk reduction guidelines should be followed to prevent cardiovascular disease in all young adults.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

